Roche Pharma India has launched a subcutaneous Tecentriq injection for eligible lung cancer patients. The shorter dosing time ...

On World No Tobacco Day, experts warn that vaping among Indian youth could trigger rising cancer risks, nicotine addiction, ...

Approved by the Drugs Controller General of India around two months ago for adjuvant and metastatic non-small cell lung cancer, Tecentriq SC is now available across India with more than 100 patients ...

Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment.But now with the launch of the ...

If cigarettes aren’t the culprit, what is? Scientists and doctors point to three distinct, overlapping environmental and ...

Roche launched Tecentriq SC in India, reducing lung cancer immunotherapy delivery time from hours to just seven minutes.

For many lung cancer patients in India, treatment is not only about the drug. It is also about the day built around it: the ...

Public health experts report a worrying rise in lung cancer cases among non-smokers, especially women, across southern India. Studies point to environmental pollution, household exposure and genetic ...

The risk of tobacco is that the damage it does is frequently delayed and accumulative and largely preventable. The World ...

A new subcutaneous formulation of the immunotherapy drug Tecentriq has been introduced in India, allowing lung cancer treatment to be administered in about seven minutes—potentially reducing hospital ...